ESC Premium Access

When will be appropriate time for P2Y12 inhibitors dose de-escalation?

Congress Presentation

About the speaker

Mr Matthew Chung

Busan (Korea (Republic of))
0 follower

9 more presentations in this session

Risk stratification for ischemic and bleeding events in patients using a potent P2Y12 inhibitor

Speaker: Doctor Y. Park (Changwon, KR)

Thumbnail

Clinical effects of beta blocker selectivity and dosage regimens in acute myocardial infarction: propensity-score matching analysis

Speaker: Professor U. Kim (Daegu, KR)

Thumbnail

Three for two - a meta-analysis on the optimal antithrombotic regimen in patients undergoing coronary stent implantation with an indication to anticoagulation therapy

Speaker: Doctor F. Fortuni (Perugia, IT)

Thumbnail

Patients eligible for prolonged dual antiplatelet treatment one year after acute coronary syndrome according to the of PRECISE-DAPT score and DAPT score

Speaker: Doctor A. Cordero (Elche, ES)

Thumbnail

Single agent clopidogrel is associated with increased all cause mortality compared with aspirin only treatment.

Speaker: Mr V. Parmar (Bushey, GB)

Thumbnail

Access the full session

Poster Session 2 - Coronary artery disease: pharmacotherapy

Speakers: Mr M. Chung, Doctor Y. Park, Professor U. Kim, Doctor F. Fortuni, Doctor A. Cordero...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb